
Following these guidelines can transform your health from head to toe, study suggests
Life's Simple 7 is the American Heart Association's guidelines for achieving and maintaining ideal cardiovascular health. The factors include not smoking, a nutritious diet, regular exercise, a healthy weight, optimal blood pressure, controlled blood sugar and well-managed cholesterol.
Researchers reviewed 483 studies on the impacts of maximizing Life's Simple 7 on the health of many different body systems over the course of people's lives in a meta-analysis published Wednesday in the Journal of the American Heart Association.
Maintaining ideal levels of at least three of Life's Simple 7 metrics was associated with a lower risk of cardiovascular disease, even if someone had a genetic predisposition, according to the data. And better scores across all of the factors showed benefits in many body systems beyond cardiovascular health.
'A few years ago, we learned that heart health and brain health are very closely tied. Through this review, we found that almost every organ system and bodily function also benefits from maintaining the healthy lifestyle behaviors of Life's Simple 7,' said lead study author Dr. Liliana Aguayo, a research assistant professor at the Nell Hodgson Woodruff School of Nursing and the Global Diabetes Research Center at Emory University in Atlanta, in a statement.
'We were pleasantly surprised to find that Life's Simple 7 at optimal levels touched every aspect of health, from head to toe. It goes well beyond just cardiovascular health to encompass whole-body health,' she added.
The researchers conducted a systemic review of studies that followed a gold standard approach, said Dr. Nour Makarem, assistant professor of epidemiology and co-leader of the Chronic Disease Unit at the Columbia University Mailman School of Public Health in New York City. Makarem was not involved in the research.
One of the most significant findings of the research is that a little change makes a big difference when it comes to lifestyle and health, Aguayo said.
The study assessed adherence to Life's Simple 7 using a scale from 0 to 14 points.
Each improvement by 1 point was associated with an 11% decrease in dementia risk, a 6% decreased risk of eye disease, a 23% decreased risk of fatty liver disease, and an 11% decreased risk of chronic kidney disease, Aguayo said.
'This means that small changes, for example, moving from obesity to overweight, adding any physical activity even if below recommended levels counted as progress,' she said.
Many of the studies showed an adherence to Life's Simple 7 was associated with maintaining brain and lung function, vision and hearing, and teeth and muscle strength over the course of aging, according to the data.
The studies included in the meta-analysis used Life's Simple 7 to evaluate lifestyle behaviors, but the AHA has since updated the metrics to Life's Essential 8.
The new guidelines are more comprehensive, such as including avoiding secondhand smoke, vaping and nicotine products in the not smoking factor and pointing people to the Mediterranean diet or DASH diet under the healthy eating metric, Makarem said. DASH stands for Dietary Approaches to Stop Hypertension; high blood pressure is a major contributor to heart disease and stroke.
Importantly, the update added an eighth metric that recognizes the role of sleep in long-term health, he added.
Good sleep means seven to nine hours a night for most adults, 10 to 16 hours for children ages 5 and younger, 9 to 12 hours for kids ages 6 to 12, and 8 to 10 hours for adolescents ages 13 to 18, according to the AHA.
The study confirms that adopting a healthy lifestyle is important to achieve optimal health as well as managing the conventional risk factors for cardiovascular disease –– weight, blood pressure, cholesterol and blood sugar, Aguayo said.
Everyday lifestyle choices have a big impact on overall health, and it's worth it to take steps toward better cardiovascular health, Aguayo said.
'The key message is that it is never too early or too late to make small, feasible changes,' she said in an email. 'Small improvements in diet, physical activity, smoking, or managing risk factors (weight, blood pressure, cholesterol and sugar) can have meaningful benefits, not just for heart health, but for all the body, from head to toe.'
For a heart-healthy diet, Makarem recommends focusing on plant-based foods such as fruits, vegetables, legumes and whole grains and consuming lean proteins such as fish. She also recommended limiting processed foods, sodium and sugar-sweetened beverages.
Adults should engage in 150 minutes of moderate physical activity — like walking, dancing or gardening — or 75 minutes of vigorous physical activity a week, Makarem added.
Even considering how impactful small changes can be, ideal cardiovascular health is very rare –– with less than 4% of people worldwide meeting the criteria, Aguayo said.
'We must do more to support young people, especially women, by making it easier, more affordable, and achievable for all to improve their cardiovascular health,' she added. 'Cardiovascular disease is still the number one killer of women. Supporting the heart health of young people and women is both cost-effective and the right thing to do.'
Sign up for CNN's Fitness, But Better newsletter series. Our seven-part guide will help you ease into a healthy routine, backed by experts.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
18 minutes ago
- Yahoo
Dr. Michael Rimlawi Announces National Scholarship for Aspiring Physicians, Supporting Future Leaders in Medicine
Dr. Michael Rimlawi DALLAS, July 17, 2025 (GLOBE NEWSWIRE) -- The Dr. Michael Rimlawi Scholarship for Future Doctors proudly announces its 2026 application cycle, inviting undergraduate students with aspirations of entering the medical field to apply. Established by renowned spine surgeon Dr. Michael Rimlawi, the scholarship aims to recognize and encourage promising future physicians who are committed to improving healthcare through compassion, innovation, and excellence. The Dr. Michael Rimlawi Scholarship for Future Doctors is open to undergraduate students enrolled at accredited colleges or universities across the United States who are pursuing a career in medicine. Applicants are required to submit an original and thoughtful essay responding to the following prompt: 'What inspired you to pursue a career in medicine, and how do you hope to make a difference in the field?' Essays must be between 500 and 750 words, reflecting a genuine passion for medicine and a clear vision for contributing to the healthcare profession. Dr. Michael Rimlawi, who serves as the driving force behind this initiative, believes that encouraging the next generation of doctors is vital for the continued advancement of patient care and medical practice. Dr. Michael Rimlawi is widely recognized for his groundbreaking work in minimally invasive spine surgery. Combining orthopedic and neurosurgical principles, Dr. Michael Rimlawi has developed and performed transformative procedures designed to reduce recovery times and enhance surgical accuracy. His role as the first surgeon in the United States to carry out the Globus Minimally Invasive XLIF procedure highlights his commitment to medical progress. In addition to his work in the operating room, Dr. Michael Rimlawi is dedicated to mentoring emerging medical professionals. Through the Dr. Michael Rimlawi Scholarship for Future Doctors, he seeks to nurture those who display both academic potential and a sincere dedication to advancing the quality of care for patients. This one-time award provides meaningful support to help offset educational expenses and encourage continued academic success. The application window is open now, with a submission deadline of January 15, 2026. The scholarship winner will be formally announced on February 15, 2026, following a careful review of all eligible essays. The Dr. Michael Rimlawi Scholarship for Future Doctors does not place any restrictions based on city or state, offering a national opportunity to talented students across the country. By supporting these aspiring physicians, Dr. Michael Rimlawi continues his mission to advance the future of medicine beyond his surgical practice. For undergraduate students who dream of becoming doctors, the Dr. Michael Rimlawi Scholarship for Future Doctors represents not only financial assistance but also the support of a leader who has dedicated his life to raising the standards of healthcare. Applicants are encouraged to visit the scholarship's website for complete details and submission guidelines. Contact Information: Spokesperson: Dr. Michael RimlawiOrganization: Dr. Michael Rimlawi Scholarship for Future DoctorsWebsite: apply@ A photo accompanying this announcement is available at
Yahoo
18 minutes ago
- Yahoo
Waud Capital Partners Forms New Partnership with Experienced Healthcare Executive Bill Mixon
Waud Capital Partners teams up with accomplished industry executive to acquire and build a healthcare supply chain solutions company CHICAGO, July 17, 2025 /PRNewswire/ -- Waud Capital Partners ("Waud Capital"), a growth-oriented middle-market private equity firm, announced today that it has formalized an executive partnership with Bill Mixon to pursue a platform investment in the medical device and supply chain services market. Targeted sub-sectors of focus will include but are not limited to home distribution, other value-add specialty distribution, outsourced provider equipment services, and chronic care and population health management offerings that deliver value to supply chain channel partners. Waud Capital anticipates investing over $100 million of equity capital to support the initiative. Mr. Mixon is an accomplished healthcare executive with more than 30 years of operating experience across the medical device and supply chain services continuum, with particular emphasis on specialty distribution and outsourced provider equipment services. He brings deep operational expertise with an extensive focus on enhancing clinical value and improving patient outcomes through the medical supply chain. Mr. Mixon has successfully scaled several private equity-backed and publicly traded organizations through repeatable organic growth strategies as well as strategic acquisitions. Most recently, Mr. Mixon served as Chief Executive Officer of Advanced Diabetes Supply, where he led the organization through a successful sale from its private equity sponsor to Cardinal Health. Advanced Diabetes Supply is a national diabetes care management platform distributing innovative therapies including continuous glucose monitors and other diabetes-related supplies. During his time at Advanced Diabetes Supply, Mr. Mixon drove transformational growth by professionalizing the organization through salesforce productivity enhancements, executing a shift in go-to-market initiatives, and delivering margin improvements through revenue cycle initiatives and other operational efficiencies. At time of sale to Cardinal Health, Advanced Diabetes Supply had grown to $1B in revenue and served nearly a half-million patients annually. Prior to Advanced Diabetes Supply, Mr. Mixon was the Chief Executive Officer of National Seating & Mobility, a provider of comprehensive mobility solutions to patients in the home. Under Mr. Mixon's leadership at National Seating & Mobility, the organization scaled through organic and inorganic methods and successfully transacted on several different occasions to multiple private equity sponsors. Mr. Mixon began his career with the U.S. Army before holding leadership positions at large organizations such as Baxter, Phillips, and Agiliti Health. "I'm excited to partner with Waud Capital to identify and help build what we hope will be an industry-leading business that supports and improves the overall healthcare supply chain," said Mr. Mixon. "Waud Capital's executive partnership approach, dedicated ecosystem resources, and deep investing experience across relevant areas make the firm a highly attractive partner. I believe this combination will enable us to capitalize on transformative growth opportunities, and I look forward to leveraging my past experiences to drive clinical value for medical professionals, manufacturers, payors and most importantly, patients." "We are thrilled to partner with Bill," said Mike Lehman, Principal at Waud Capital. "He is an exceptional executive who has created value and driven multiple successful outcomes throughout his career in a sector we find highly attractive. The healthcare supply chain markets are highly fragmented with significant opportunities for organizations to deliver value-add solutions and address substantial challenges for key stakeholders." This executive partnership builds upon Waud Capital's extensive experience investing across the broader healthcare supply chain services and home care markets. Notable investments include Mopec Group (supplier of pathology equipment, consumables and services), PromptCare (home infusion and durable medical equipment), Provider Network Holdings (specialty medication supply management), DS Medical (home medical supplies), and recent home care investments AltoCare (in-home senior care), and Concierge Home Care (skilled home healthcare). "The partnership with Bill is another example of Waud Capital's executive-first campaign approach and commitment to support accomplished executive leaders with the full ecosystem of resources to execute transformative growth strategies in large, growing markets," said Kyle Lattner, Partner at Waud Capital. "This is our second dedicated campaign in the medical device and supply chain services market in the last two years and we are thrilled about the prospects of what we can accomplish during our partnership with Bill." About Waud Capital PartnersBased in Chicago and founded by Reeve B. Waud, Waud Capital Partners is a growth-oriented private equity firm with over 30 years of investing experience. Waud Capital Partners seeks to partner with experienced management teams to build market-leading companies within two industries: healthcare and software & technology. Since its founding in 1993, Waud Capital has successfully completed more than 500 investments, including platform companies and follow-on opportunities. For additional information on Waud Capital, please visit Investment Professional Contacts:Kyle Lattner, Partner(312) 676-8404klattner@ Mike Lehman, Principal(312) 676-8446mlehman@ Business Development Contact:Phil Olson, Partner – Business Development(312) 676-8401polson@ Investor Relations Contact:Jessica Schmitt, Head of Investor Relations(312) 676-8400jschmitt@ View original content to download multimedia: SOURCE Waud Capital Partners


Gizmodo
20 minutes ago
- Gizmodo
Our Best View Yet of Interstellar Comet 3I/ATLAS
A comet unlike any seen before has fixated astronomers around the world. An observatory in Hawaii has unveiled the most stunning image of this ancient interstellar visitor yet. The Gemini North telescope on Maunakea, Hawaii, recently snapped a close-up of 3I/ATLAS, the third interstellar object ever discovered. The telescope's highly sensitive Multi-Object Spectrograph captured the comet's compact coma—a cloud of gas and dust surrounding its icy nucleus—in striking detail. 3I/ATLAS is inbound to the inner solar system, and as it approaches the Sun and heats up, its coma will expand and make the comet appear brighter. Observing this uptick in activity, known as cometary outgassing, will allow astronomers to gain more insight into the composition of 3I/ATLAS. Understanding what this interstellar comet is made of will offer a glimpse of the conditions and processes that shaped the distant star system from which it came. 'The sensitivity and scheduling agility of the International Gemini Observatory has provided critical early characterization of this interstellar wanderer,' Martin Still, NSF program director for the International Gemini Observatory, said in a statement. 'We look forward to a bounty of new data and insights as this object warms itself on sunlight before continuing its cold, dark journey between the stars.' The International Astronomical Union's Minor Planet Center confirmed that this comet came from outside our solar system on July 2. Since then, astronomers have been racing to gather as much data on it as possible. Preliminary findings suggest 3I/ATLAS is the oldest comet ever found, roughly 2 billion years older than our solar system. What's more, it appears to have come from an underexplored region of the Milky Way's galactic disk. This is the disk-like component of our galaxy containing stars, gas, and dust that rotates in a circular coplanar motion around the center of the galaxy. Based on its trajectory, 3I/ATLAS likely came from the thick part of the disk, which contains roughly 10% of the stellar mass of the Milky Way. Stars located in the thick disk are generally much older than those located in the galaxy's thin disk. This comet is older, larger, and faster than the two interstellar objects that came before it: 'Oumuamua and Comet 2I/Borisov. One recent study, which has yet to undergo peer review, found that 3I/ATLAS has a hyperbolic velocity of about 37 miles per second (60 kilometers per second). That's roughly twice the speed of both 'Oumuamua and Borisov. The researchers also estimated the newly discovered comet to be up to 6 miles (10 kilometers) wide, which would make it 100 times wider than 'Oumuamua and 10 times wider than Borisov. If 3I/ATLAS truly is that big, this would imply that galaxies are far more efficient at making these kinds of objects than scientists thought. The study authors note, however, that estimations of this comet's size will likely shrink as astronomers gather more observations. The Gemini Observatory and many others across the globe will continue using a wide variety of telescopes to observe 3I/ATLAS as it rockets toward the Sun. The comet should make its closest approach to our home star on October 29 and its closest approach to Earth on October 30. It will keep a safe distance from our planet, but the flyby will still allow astronomers to gather more detailed observations of this comet before it leaves our solar system for good. Such studies could begin to unravel the many mysteries of 3I/ATLAS, as its characteristics remain largely unknown. Still, it's already becoming clear that this interstellar comet is totally different from any we've seen before, offering brand new insights into galactic processes beyond our solar system.